ArticleJournal of virology2025
Replication-competent adenovirus reporters utilizing endogenous viral expression architecture.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AdamiForge: a modular reverse genetics tool for human adenovirus type 12 (HAdV-A12).Microbiology spectrum · 2026Article
- Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating viruses.bioRxiv : the preprint server for biology · 2026Article
- Understanding the performance of HIV-1 viral vector vaccines: adenovirus and poxvirus case studies.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Adenoviruses are double-stranded DNA viruses widely used as platforms for vaccines, oncolytics, and gene delivery. However, tools for studying adenoviral gene expression in real time during infection remain limited. Here, we describe a set of fluorescent and bioluminescent reporter viruses built using the modular AdenoBuilder reverse genetics system and informed by high-resolution maps of Ad5 transcription. These reporters utilize endogenous early and late transcriptional units, enabling visualization of viral gene expression without exogenous promoters or splicing elements. These model viruses replicate with kinetics nearly indistinguishable from wild-type virus and have enabled real-time fluorescent imaging as well as longitudinal bioluminescent sampling from the same infected samples. Together, this next generation of adenovirus reporters provides a modular and tractable platform for studying viral gene regulation and replication dynamics in real time, with broad applications for basic research and high-throughput screening. IMPORTANCE: This research provides powerful new tools to rapidly study adenovirus gene expression and replication. By integrating fluorescent and secreted luciferase reporters into native viral regulatory elements, we enable real-time, non-destructive tracking of early and late stage infection in living cells. These modular reporters are compatible with a wide range of genetic and chemical perturbations, allowing researchers to investigate the function of specific viral genes, host interactions, and the impact of host genes and antiviral compounds. Importantly, the high-throughput nature of these systems overcomes limitations of traditional plaque assays to quantify viral replication dynamics. Our work will allow for the rapid creation of both novel infectious and replication-incompetent viral vectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.